Lemonade ($LMND) Investment Thesis: Disrupting Insurance or Burning Cash? A...
Lemonade, Inc. (NYSE: LMND) offers an intriguing chance in the insurtech sector with a "Buy" rating and a 12-month price target of $42, predicting a 25% upside. Despite current profitability...